U.S. markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.15+0.92 (+5.34%)
At close: 4:00PM EDT

18.25 +0.10 (0.55%)
After hours: 5:51PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/14/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
571.38M765.20M815.49M1.37B1.58B2.07B
Enterprise Value 3
741.42M871.04M889.55M1.39B1.58B1.96B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.772.432.714.815.697.91
Price/Book (mrq)
44.19N/AN/AN/AN/A40.22
Enterprise Value/Revenue 3
2.3010.6710.6817.5120.5226.97
Enterprise Value/EBITDA 7
-4.35-32.11-22.78-25.94-31.36-24.36

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3-79.64%
S&P500 52-Week Change 343.61%
52 Week High 394.51
52 Week Low 316.26
50-Day Moving Average 320.96
200-Day Moving Average 327.78

Share Statistics

Avg Vol (3 month) 31.15M
Avg Vol (10 day) 31.03M
Shares Outstanding 533.16M
Implied Shares Outstanding 6N/A
Float 28.28M
% Held by Insiders 115.05%
% Held by Institutions 181.56%
Shares Short (Apr 29, 2021) 46.45M
Short Ratio (Apr 29, 2021) 45.49
Short % of Float (Apr 29, 2021) 426.82%
Short % of Shares Outstanding (Apr 29, 2021) 419.45%
Shares Short (prior month Mar 30, 2021) 47.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -69.11%
Operating Margin (ttm)-50.47%

Management Effectiveness

Return on Assets (ttm)-17.16%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)321.7M
Revenue Per Share (ttm)9.72
Quarterly Revenue Growth (yoy)12.40%
Gross Profit (ttm)307.37M
EBITDA -159.13M
Net Income Avi to Common (ttm)-222.32M
Diluted EPS (ttm)-6.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)411.18M
Total Cash Per Share (mrq)12.4
Total Debt (mrq)581.22M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.33
Book Value Per Share (mrq)-6.03

Cash Flow Statement

Operating Cash Flow (ttm)-125.94M
Levered Free Cash Flow (ttm)-48.29M